Our data show some similarities with the predictive value of TMB and GEP to anti-PD-1 therapy across different tumour types.54,55 The ability of these two parameters to reflect overlapping but not always coincident aspects of tumour immunology may explain their lack of correlation. This evidence concerns the gene PDCD1 and neoplasm.